World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences


Login | Registration


ISSN: 2583-6579


Impact Factor: 6.916

ABSTRACT

MANAGEMENT OF HEMANGIOMA OF BUCCAL MUCOSA USING SCLEROSING AGENT: A CASE REPORT AND LITERATURE REVIEW

Dr. Monika Nandan*, Dr. Harmeet Singh, Dr. Gautam Khatak, Dr. Harshita Rexwal

Hemangiomas are benign soft tissue tumors the etiology of which is still unknown. The various treatment options are surgical excision, sclerosing agents, propranolol, laser therapy, cryosurgery and corticosteroids. In the present case, hemangiomas of buccal mucosa was treated using sclerosing agent. The lesion was superficial and small. Since surgical excision is an invasive procedure leading to more complications, sclerosing agent is used in the present case for its management. Patient was followed up for 6 months. No recurrences were observed. The present case report highlights the importance of using sclerosing agent for management of hemangioma. It is a non -invasive procedure and chances of recurrences are low. 

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    January 2026 Issue Now Available

    January 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming January 2026 Issue . All submissions will undergo a standard peer-review process.